Key result
Higher pre-transplant TTV load is linked to ~30% less acute rejection but more infections and graft failure.
Why the study?
Torque teno virus load is a potential surrogate marker of net immunosuppression, but the clinical significance of pre-transplant levels for early outcomes after lung transplantation remains unclear.
Does pre-transplant Torque teno virus (TTV) load predict early post-transplant infection, acute rejection, and 1-year graft failure in lung transplant recipients?
Comparison
Pre-transplant Torque teno virus levels
Design
Multicenter cohort study
Follow-up
Up to 1 year
Authors
Loading...
Supports pre-transplant TTV for immune risk stratification in lung recipients; hypothesis-generating and requires prospective validation before adoption.
Does pre-transplant Torque teno virus (TTV) load predict early post-transplant infection, acute rejection, and 1-year graft failure in lung transplant recipients?
Higher pre-transplant plasma TTV load is a strong predictor of early post-transplant infection and 1-year graft failure, but is associated with fewer acute rejection events, highlighting its potential as a biomarker for immune risk stratification.
Lee et al. (2026) studied this question. Each 1-log10 increase in pre-transplant TTV load in lung recipients increased early infection risk (aOR 15.05) and 1-year graft failure (aHR 1.40), but reduced acute rejection (aHR 0.70).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: